Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Early research (Phase 1)Looking for participantsNCT07349758
What this trial is testing

Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

Who this might be right for
Healthy VolunteerHIV Prevention
Johns Hopkins University 24
Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Early research (Phase 1)Study completedNCT02583464
What this trial is testing

Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Who this might be right for
Acquired Immunodeficiency Syndrome
Laboratorio Elea Phoenix S.A. 24
Post-approval studies (Phase 4)Study completedNCT00438152
What this trial is testing

Lopinavir Capsules to Kaletra or Invirase Tablets

Who this might be right for
HIV Infections
Royal Free Hampstead NHS Trust 53
Testing effectiveness (Phase 2)Study completedNCT00006152
What this trial is testing

See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)UnknownNCT01378936
What this trial is testing

Jail-Based Impact of Crime Intervention

Who this might be right for
Substance AbuseHIV RiskCriminogenic Thinking+3 more
George Mason University 200
Not applicableStudy completedNCT00385632
What this trial is testing

Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,224
Early research (Phase 1)Study completedNCT00984971
What this trial is testing

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Who this might be right for
HIV PreventionHIV Infections
CONRAD 18
Large-scale testing (Phase 3)Study completedNCT00002193
What this trial is testing

Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Early research (Phase 1)Study completedNCT00121121
What this trial is testing

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
French National Agency for Research on AIDS and Viral Hepatitis 70
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Not applicableStudy completedNCT00955591
What this trial is testing

Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men

Who this might be right for
Anal CancerNonneoplastic ConditionPrecancerous Condition
Jonsson Comprehensive Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT01066962
What this trial is testing

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 800
Early research (Phase 1)Study completedNCT00002346
What this trial is testing

The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 36
Testing effectiveness (Phase 2)Ended earlyNCT01737359
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC 2
Large-scale testing (Phase 3)Study completedNCT00966160
What this trial is testing

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of Cologne 215
Testing effectiveness (Phase 2)Study completedNCT00445146
What this trial is testing

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

Who this might be right for
HIV Infections
Gilead Sciences 192
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Next Page